Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT05554224)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05554224 Sponsor: Institut Investigacio Sanitaria Pere Virgili Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05554224 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People with a Body Mass Index (BMI) of 40 or higher (BMI is a measure of body weight relative to height)
People with a BMI between 35 and 40 who also have at least one of the following conditions: high blood pressure, high cholesterol, or type 2 diabetes
People who have completed a psychiatric (mental health) evaluation with a positive result
People aged 18 years or older

Who may not be able to join:

People who use legal or illegal drugs, including alcohol
People who have been diagnosed with Hepatitis
People who currently have cancer or are receiving cancer treatment
People with medical or test-based evidence of a serious illness
People with medical or test-based evidence of ongoing or sudden inflammation in the body
People with medical or test-based evidence of an infectious disease
People with medical or test-based evidence of a terminal illness

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jorge Joven, Professor, Institut Investigacio Sanitaria Pere Virgili

Phone: +34977310300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05554224

Sponsor: Institut Investigacio Sanitaria Pere Virgili

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: +34977310300

More information: https://clinicaltrials.gov/study/NCT05554224

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People with a Body Mass Index (BMI) of 40 or higher (BMI is a measure of body weight relative to height)
People with a BMI between 35 and 40 who also have at least one of the following conditions: high blood pressure, high cholesterol, or type 2 diabetes
People who have completed a psychiatric (mental health) evaluation with a positive result
People aged 18 years or older

Who may not be able to join:

People who use legal or illegal drugs, including alcohol
People who have been diagnosed with Hepatitis
People who currently have cancer or are receiving cancer treatment
People with medical or test-based evidence of a serious illness
People with medical or test-based evidence of ongoing or sudden inflammation in the body
People with medical or test-based evidence of an infectious disease
People with medical or test-based evidence of a terminal illness

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut Investigacio Sanitaria Pere Virgili

Registry

ClinicalTrials.gov

Start date

25 June 2008

Est. completion

31 December 2028

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Weight change; Type 2 diabetes mellitus incidence; Hypertension incidence; Chronic liver diseases incidence; Dyslipidemia incidence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov